Phosphorylation of Minichromosome Maintenance 3 (MCM3) by Checkpoint Kinase 1 (Chk1) Negatively Regulates DNA Replication and Checkpoint Activation

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2015 Mar 27

PMID 25809478

Citations 19

Authors

Xiangzi Han

Franklin Mayca Pozo

Jacob N Wisotsky

Benlian Wang

James W Jacobberger

Youwei Zhang

Affiliations

Soon will be listed here.

Abstract

Mechanisms controlling DNA replication and replication checkpoint are critical for the maintenance of genome stability and the prevention or treatment of human cancers. Checkpoint kinase 1 (Chk1) is a key effector protein kinase that regulates the DNA damage response and replication checkpoint. The heterohexameric minichromosome maintenance (MCM) complex is the core component of mammalian DNA helicase and has been implicated in replication checkpoint activation. Here we report that Chk1 phosphorylates the MCM3 subunit of the MCM complex at Ser-205 under normal growth conditions. Mutating the Ser-205 of MCM3 to Ala increased the length of DNA replication track and shortened the S phase duration, indicating that Ser-205 phosphorylation negatively controls normal DNA replication. Upon replicative stress treatment, the inhibitory phosphorylation of MCM3 at Ser-205 was reduced, and this reduction was accompanied with the generation of single strand DNA, the key platform for ataxia telangiectasia mutated and Rad3-related (ATR) activation. As a result, the replication checkpoint is activated. Together, these data provide significant insights into the regulation of both normal DNA replication and replication checkpoint activation through the novel phosphorylation of MCM3 by Chk1.

Citing Articles

Minichromosome Maintenance Proteins: From DNA Replication to the DNA Damage Response.

Malysa A, Zhang X, Bepler G Cells. 2025; 14(1.

PMID: 39791713 PMC: 11719910. DOI: 10.3390/cells14010012.

The MCM2-7 Complex: Roles beyond DNA Unwinding.

Rankin B, Rankin S Biology (Basel). 2024; 13(4).

PMID: 38666870 PMC: 11048021. DOI: 10.3390/biology13040258.

MYO10 regulates genome stability and cancer inflammation through mediating mitosis.

Pozo F, Geng X, Miyagi M, Amin A, Huang A, Zhang Y Cell Rep. 2023; 42(5):112531.

PMID: 37200188 PMC: 10293887. DOI: 10.1016/j.celrep.2023.112531.

Incorporation of a histone mutant with H3K56 site substitution perturbs the replication machinery in mouse embryonic stem cells.

Kang X, Yang X, Guo X, Li Y, Yang C, Wei H J Mol Cell Biol. 2022; 14(3).

PMID: 35259279 PMC: 9254884. DOI: 10.1093/jmcb/mjac014.

ZMIZ2 promotes the development of triple-receptor negative breast cancer.

Zou X, Liu Y, Di J, Wei W, Watanabe N, Li J Cancer Cell Int. 2022; 22(1):52.

PMID: 35101047 PMC: 8802436. DOI: 10.1186/s12935-021-02393-x.

References

Ran F, Hsu P, Wright J, Agarwala V, Scott D, Zhang F . Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013; 8(11):2281-2308. PMC: 3969860. DOI: 10.1038/nprot.2013.143. View

Wang J, Han X, Feng X, Wang Z, Zhang Y . Coupling cellular localization and function of checkpoint kinase 1 (Chk1) in checkpoints and cell viability. J Biol Chem. 2012; 287(30):25501-9. PMC: 3408180. DOI: 10.1074/jbc.M112.350397. View

Pereverzeva I, Whitmire E, Khan B, Coue M . Distinct phosphoisoforms of the Xenopus Mcm4 protein regulate the function of the Mcm complex. Mol Cell Biol. 2000; 20(10):3667-76. PMC: 85659. DOI: 10.1128/MCB.20.10.3667-3676.2000. View

Takai H, Tominaga K, Motoyama N, Minamishima Y, Nagahama H, Tsukiyama T . Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice. Genes Dev. 2000; 14(12):1439-47. PMC: 316691. View

Liu Q, Guntuku S, Cui X, Matsuoka S, Cortez D, Tamai K . Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev. 2000; 14(12):1448-59. PMC: 316686. View

Tye B, Sawyer S . The hexameric eukaryotic MCM helicase: building symmetry from nonidentical parts. J Biol Chem. 2000; 275(45):34833-6. DOI: 10.1074/jbc.R000018200. View

Bell S, Dutta A . DNA replication in eukaryotic cells. Annu Rev Biochem. 2002; 71:333-74. DOI: 10.1146/annurev.biochem.71.110601.135425. View

Sorensen C, Syljuasen R, Falck J, Schroeder T, Ronnstrand L, Khanna K . Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell. 2003; 3(3):247-58. DOI: 10.1016/s1535-6108(03)00048-5. View

Tercero J, Longhese M, Diffley J . A central role for DNA replication forks in checkpoint activation and response. Mol Cell. 2003; 11(5):1323-36. DOI: 10.1016/s1097-2765(03)00169-2. View

10.

Merrick C, Jackson D, Diffley J . Visualization of altered replication dynamics after DNA damage in human cells. J Biol Chem. 2004; 279(19):20067-75. DOI: 10.1074/jbc.M400022200. View

11.

Cortez D, Glick G, Elledge S . Minichromosome maintenance proteins are direct targets of the ATM and ATR checkpoint kinases. Proc Natl Acad Sci U S A. 2004; 101(27):10078-83. PMC: 454167. DOI: 10.1073/pnas.0403410101. View

12.

Tsao C, Geisen C, Abraham R . Interaction between human MCM7 and Rad17 proteins is required for replication checkpoint signaling. EMBO J. 2004; 23(23):4660-9. PMC: 533049. DOI: 10.1038/sj.emboj.7600463. View

13.

Yoo H, Shevchenko A, Shevchenko A, Dunphy W . Mcm2 is a direct substrate of ATM and ATR during DNA damage and DNA replication checkpoint responses. J Biol Chem. 2004; 279(51):53353-64. DOI: 10.1074/jbc.M408026200. View

14.

Zachos G, Rainey M, Gillespie D . Chk1-dependent S-M checkpoint delay in vertebrate cells is linked to maintenance of viable replication structures. Mol Cell Biol. 2005; 25(2):563-74. PMC: 543419. DOI: 10.1128/MCB.25.2.563-574.2005. View

15.

Unsal-Kacmaz K, Mullen T, Kaufmann W, Sancar A . Coupling of human circadian and cell cycles by the timeless protein. Mol Cell Biol. 2005; 25(8):3109-16. PMC: 1069621. DOI: 10.1128/MCB.25.8.3109-3116.2005. View

16.

Wang J, Engle S, Zhang Y . A new in vitro system for activating the cell cycle checkpoint. Cell Cycle. 2011; 10(3):500-6. PMC: 3050501. DOI: 10.4161/cc.10.3.14753. View

17.

Chen P, Luo C, Deng Y, Ryan K, Register J, Margosiak S . The 1.7 A crystal structure of human cell cycle checkpoint kinase Chk1: implications for Chk1 regulation. Cell. 2000; 100(6):681-92. DOI: 10.1016/s0092-8674(00)80704-7. View

18.

Ilves I, Tamberg N, Botchan M . Checkpoint kinase 2 (Chk2) inhibits the activity of the Cdc45/MCM2-7/GINS (CMG) replicative helicase complex. Proc Natl Acad Sci U S A. 2012; 109(33):13163-70. PMC: 3421224. DOI: 10.1073/pnas.1211525109. View

19.

Frigola J, Remus D, Mehanna A, Diffley J . ATPase-dependent quality control of DNA replication origin licensing. Nature. 2013; 495(7441):339-43. PMC: 4825857. DOI: 10.1038/nature11920. View

20.

Syljuasen R, Sorensen C, Hansen L, Fugger K, Lundin C, Johansson F . Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage. Mol Cell Biol. 2005; 25(9):3553-62. PMC: 1084285. DOI: 10.1128/MCB.25.9.3553-3562.2005. View